GoodRx Holdings, Inc. (GDRX) Reports In-Line Q3 EPS, Offers Guidance

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q3 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $195.1 million versus the consensus estimate of $194.89 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q4 2021 revenue of $212-222 million, versus the consensus of $217 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Nucor projects Q3 2026 earnings above prior year, below estimates
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in